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Abstract 
BACKGROUND: Nowadays, spinal anaesthesia is a suitable choice for most elective and emergency cesarean 
section (C-section) deliveries. 
AIM: This study aimed to determine the effect of adding low-dose naloxone to intrathecal morphine on 
postoperative pain and morphine related side effects after C-section. 
MATERIAL AND METHODS: In the present double-blind, randomised clinical trial, 70 women aged over 18 
years, who were candidates for elective medical C-section under spinal anaesthesia were selected and randomly 
assigned to either the study group or the control group. For spinal anaesthesia, 10 mg of Bupivacaine plus 100 μg 
of morphine was administered for all patients. However, patients in the study group received 20 µg of naloxone 
intrathecally; but the patients in the control group only received normal saline as a placebo. After surgery, patient-
controlled analgesia (PCA) pump with paracetamol (Apotel®) was connected to each patient. The intensity of 
postoperative pain in the patients was evaluated and recorded using Visual Acuity Screening (VAS) at 2, 4, 6 and 
24 hours after the surgery. The patients were also examined for postoperative nausea and pruritus. 
RESULTS: Regardless of the groups to which the patients were assigned, a significant difference in pain intensity 
was observed during the study period (time effect; p < 0.001). Although the intensity of pain was lower in the 
study group, the difference was not statistically significant (group effect; p = 0.84). Also, there was no group time 
interaction between pain intensity and the times studied (p = 0.61). The incidence rates of postoperative nausea 
and pruritus were significantly lower in the study group compared to the control group (p < 0.001). 
CONCLUSION: According to the results of this study, adding low dose naloxone to intrathecal morphine did not 
significantly change postoperative pain intensity in the patients undergone elective C-section using spinal 
anaesthesia; however, significantly decreased the severity of postoperative nausea and pruritus. 
 
 
 
 
 
Introduction 
 
Cesarean section (C-section) is one of the 
major obstetric and gynecologic surgeries. Following 
C-section, patients experience different degrees of 
pain due to complex physiological issues in response 
to tissue damage and uterine contractions [1], [2]. 
Postoperative pain can lead to patient's failure to 
discharge respiratory secretions, ileus and prolonged 
bed rest, which increases the risk of deep vein 
thrombosis and other complications. Also, it can 
cause delayed patient discharge from hospital, 
prolonged recovery time, lack of patient satisfaction 
with hospital care and increased recovery costs. 
Moreover, acute pain after C-section can delay the 
onset of breastfeeding [3], [4]. Therefore, finding a 
way to provide a maximum pain relief feeling and 
calmness, with the minimum complications, is one of 
the most important issues after C-section [5], [6]. 
Various studies have been conducted so far 
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on reducing patients’ pain intensity after C-section. 
The growing number of studies indicates that no clear 
and reliable method exists yet for reducing post-
cesarean pain; in other words, relieving pain in the 
early post-cesarean stages is still a challenge [7]. 
Nowadays, spinal anaesthesia is a suitable choice for 
most elective and emergency cesarean deliveries [8], 
[9]. So far, various drugs have been used intrathecally 
for spinal anaesthesia, and among these drugs, local 
anaesthetics are the most important ones. Opioids are 
another group of drugs that are widely used for 
neuraxial analgesia, especially in combination with 
other drugs. Using opioids in spinal anaesthesia 
increases its quality, reduces its complications and 
has advantages in postoperative analgesia [10], [11]. 
Additionally, it may minimize the risk of 
hypotension following spinal anesthesia, especially in 
patients undergoing C-section. Morphine is one of the 
opioids commonly used for spinal anesthesia in 
patients undergoing C-section. Despite the benefits of 
using intrathecal morphine in spinal anesthesia, it may 
cause complications such as postoperative nausea, 
vomiting, pruritus, sedation, and respiratory 
depression. Furthermore, the quality of analgesia and 
the incidence of intrathecal morphine side effects are 
dose-dependent and usually increase with increasing 
dose [12], [13]. Therefore, it seems reasonable to use 
compounds enhancing the effectiveness of opioids 
and reducing their dosage, side effects and pain 
intensity in patients. 
Naloxone, as a μ-opioid receptor antagonist, 
is one of the drugs that can enhance the 
postoperative pain-relieving effects of opioids and 
reduce their dosage. Releasing endogenous opioids 
and the regulation of opioid receptors is one the 
probable mechanism of naloxone in enhancing the 
opioids' analgesic effect [14], [15]. Previous studies 
showed conflicting results regarding the effect of low-
dose naloxone in combination with opioids on pain 
intensity, doses of opioids and side effects of opioid 
administration [15], [16], [17], [18], [19]. Therefore, the 
aim of this study was to determinate the effect of 
adding low-dose naloxone to intrathecal morphine on 
post-cesarean pain intensity and complications. 
 
 
Material and Methods 
 
In the present double-blind, randomised 
controlled clinical trial, patients who were scheduled 
for elective C-section and referred to Imam Khomeini 
Educational Hospital in Sari, were evaluated. Those 
patients who meet the inclusion criteria were initially 
selected. The inclusion criteria were being a candidate 
for elective medical C-section under spinal 
anaesthesia, being over 18 years of age, weight 60-80 
kg, giving birth to the first or the second baby and 
being ASA class 1 or 2. Also, patients with known 
sensitivity to bupivacaine or morphine, failure of spinal 
anaesthesia, reluctance to continue with the study, 
prolonged duration of surgery (more than 1.5 hours), 
and in whom unpredicted adverse effects or 
complications occurred during surgery were excluded 
from the study. 
After obtaining the approval of the institutional 
ethics committee (reference number: 
IR.MAZUMS.IMAMHOSPITAL.REC.13997.044) and 
obtaining informed consent, 70 patients included in 
the study. Then, the participants were randomly 
allocated into two equal-sized groups of study and 
control (n = 35). All patients received 500 ml of 
lactated Ringer's solution intravenously after entering 
the operation room. To monitor the patients, non-
invasive blood pressure measurement, pulse oximetry 
and electrocardiogram (ECG) monitoring were used. 
Spinal anaesthesia was performed in a sitting position 
and under aseptic condition by an anesthesiologist, 
who was unaware of the contents of the syringes. The 
anesthesiologist inserted a needle (B. Braun 25G) into 
the space between L3 and L4 or L4 and L5 vertebrae 
and entered the subarachnoid space from the midline. 
Needle placement in dura mater space was confirmed 
by the free flow of cerebrospinal fluid. The needle 
bevel was placed in the cephalad direction, and the 
anaesthetic drugs were injected. For spinal 
anaesthesia, 10 mg of 0.5% bupivacaine plus 100 μg 
of morphine were administered for every patient. 
Besides, 20 µg of naloxone (produced in Toliddaru 
Co.) was injected into the intrathecal space in the 
patients of the study group, but the patients in the 
control group only received normal saline as placebo. 
After the completion of the injection process, 
the patient was placed in the supine position; her 
shoulders were raised and using nasal cannula 100% 
oxygen was administered. After ensuring the proper 
level of the sensory blockade and hemodynamic 
stability of the patient, the surgery started. The 
surgical technique (i.e., Pfannenstiel transverse 
incision) was the same for all patients. The patients 
had not received any sedatives before the surgery. 
After completion of the surgery, patient-controlled 
analgesia (PCA) pump was connected to each 
patient. The PCA pump included 4 gr Apotel® 
(Paracetamol), which had been reached to 120 ml 
(the total volume of the pump) with normal saline. The 
PCA pumps were set as follows: the bolus dose of 0.5 
ml, 15 minutes lockout and a background infusion rate 
of 4 cc/h. Diclofenac suppository was also used if a 
patient’s pain had not been properly managed. The 
primary outcome was postoperative pain intensity, 
and the secondary outcomes were postoperative total 
morphine consumption and incidence of postoperative 
nausea and pruritus. The intensity of postoperative 
pain was evaluated using the visual analogue scale 
(VAS) at 2, 4, 6 and 24 hours after the surgery. The 
patients were also examined for postoperative nausea 
and pruritus. The evaluations were done by a nurse, 
who was unaware of the study groups; but she had 
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already received adequate training for those 
evaluations. Also, patients in the two groups were not 
aware of the study groups. The patients’ body mass 
index (BMI) and characteristics such as age, dwelling 
place, education level, and operating room duration 
were also recorded at the beginning of the study.  
 
 
Results 
 
In this study, 83 women who were scheduled 
for C-section under spinal anaesthesia were initially 
selected. Among them, 70 patients met the inclusion 
criteria and entered the study (Figure 1). 
 
Figure 1: Flowchart of the study 
 
According to the results of the study, the 
mean BMIs of the patients in the study and control 
groups were respectively 30.17 ± 2.71 and 31.73 ± 
2.64 (p = 0.517). There were also no significant 
differences between the two groups in terms of other 
demographic and clinical characteristics (Table 1). 
Table 1: Demographic and clinical characteristics of the 
patients in both groups 
Variable  
Group 
p-value 
Study Control 
Age (year) 31.34 ± 6.14 33.23 ± 5.06 0.16 
Dwelling place 
Village 11 (31.45) 10 (28.6%) 
0.53 
City 24 (68.7%) 25 (70.14%) 
Education level 
Below high school diploma 9 (25.7%) 10 (28.6%) 
0.92 High school diploma 22 (62.9%) 20 (57.1%) 
Bachelor of Science or above 4 (11.4%) 5 (14.3%) 
Duration of surgery (mean ± SD) 45.32 ± 8.25 43.95 ± 9.55 0.35 
 
The mean and SD of postoperative pain 
intensity in each of the two groups are presented in 
Table 2. As can be seen, regardless of the groups to 
which the patients were assigned, there was 
statistically significant difference in pain intensity 
between the two groups (time effect; P < 0.001); 
regardless of the study’s timing, although the intensity 
of pain was lower in the study group, the difference 
was not statistically significant (group effect; p = 0.84). 
Also, there was no group time interaction between 
pain intensity and the times studied (p = 0.61). 
Table 2: The mean postoperative pain intensity in the two 
groups 
Variable 
Group 
Study (n = 35) Control (n = 35) 
VAS pain score, T1 1.1 (0.67) 1.5 (0.81) 
VAS pain score, T2 1.51 (1.11) 1.84 (1.24) 
VAS pain score, T3 3.14 (1.23) 3.92 (1.53) 
VAS pain score, T4 2.65 (1.29) 2.92 (1.61) 
F statistics  
(P value) 
Time effect 114.73 (< 0.001) 
Group effect 0.41 (> 0.05) 
Interaction effect 0.608 (> 0.05) 
 
As shown in Table 3, the incidence rates of 
postoperative nausea and pruritus were significantly 
lower in the study group compared to the control 
group (p < 0.001). 
Table 3: The incidence rates of postoperative nausea and 
pruritus in the two groups 
Variable 
Group 
P-value 
Study Control 
Nausea 
Yes 0 13 
< 0.001 
No 35 11 
Pruritus 
Yes 1 34 
< 0.001 
No 16 19 
 
Means of paracetamol (Apotel®) use in the 
study and control groups were respectively 3.13 ± 
0.15 gr and 3.85 ± 0.26 gr. Although the patients in 
the control group used Apotel® more than those in the 
study group, the difference was not statistically 
significant (p = 0.56). Also, out of the 70 patients in 
two groups, 11 patients needed diclofenac 
suppository in the first 24 hours after the surgery (4 in 
the study group and 7 in the control group); the 
difference, however, was not statistically significant (p 
= 0.55). 
 
 
Discussion 
 
According to the result of this study, adding 
naloxone to intrathecal morphine, compared to 
intrathecal morphine alone, had no statistically 
significant effect on morphine-induced pain reduction 
during the study period. The results indicated that the 
incidence rates of postoperative nausea and pruritus 
were significantly lower in the study group than the 
control group. In a study by Cepeda et al., [18] which 
has been done on patients undergoing less than 3 
hours length surgeries, showed that the addition of 
low-dose naloxone (6 μg/cc) to PCA morphine was 
significantly related to more treatment failure, greater 
pain intensity, higher opioid requirements, less pain 
relief and lower patient satisfaction. They did not 
report any statistically significant difference in 
morphine-induced complications between their two 
study groups. Similarly, the results of their other study 
[20] showed that the infusion of ultra-low-dose 
naloxone and morphine via PCA pump was not 
effective in reducing the patients’ postoperative pain 
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intensity. However, they reported lower rates of 
nausea and pruritus in the patients who received 
naloxone plus morphine compared to those who 
received only morphine. Bijur et al., [21] examined the 
effects of adding different doses of naloxone (i.e., 0.1 
ng/kg, 0.01 ng/kg and 0.001 ng/kg) to morphine on 
pain intensities of the patients referring to the 
emergency department due to their acute pain. They 
found that the addition of the three examined doses of 
naloxone to morphine did not have any significant 
effect on morphine-induced pain reduction and 
complications. 
Koo et al., [22] conducted a study on the 
patients undergoing thyroid surgery. They reported 
that the addition of 0.05 μg kg/h continuous infusion of 
naloxone to remifentanil, compared to remifentanil 
alone, had no significant effect on reducing 
postoperative pain intensity in their examined patients. 
They also did not report any significant difference 
between the two groups in terms of postoperative 
complications. In a Canadian study on the patients 
with chronic low-back pain, Nekoui et al., [23] reported 
that the combination of naloxone and intrathecal 
morphine had no significant effect on enhancing 
analgesic effects of morphine and reducing morphine-
induced complications. Rebel et al., [24] conducted a 
study on the patients undergoing radical 
prostatectomy; they reported that high-dose 
intrathecal opioid administration along with 
intravenous naloxone infusion significantly reduced 
postoperative pains and opioid-induced complication. 
In another study on the patients undergoing lumbar 
discectomy, it was shown that the infusion of ultra-
low-dose naloxone (0.25 μg/kg/h) with morphine via 
PCA pump significantly decreased postoperative pain 
and morphine-induced nausea and pruritus [19]. It 
was also shown that addition of low-dose naloxone 
(1/20 to 1/10 doses of morphine) could temporarily 
increase analgesic effects of morphine; while higher 
doses (equal to morphine dose) decrease those 
effects [25]. The results of a study by Firouzian et al., 
[26] showed that adding an ultra-low dose of 
intrathecal naloxone (20 μg) to intrathecal morphine 
significantly reduce postoperative pain and pruritus 
and nausea in patients undergoing laminectomy with 
spinal fusion. 
Complications of neuraxial opioids are the 
results of the drug being present in CSF, or systemic 
circulation of blood or even both. One of the 
suggested solutions for reducing the incidence of 
these complications is the use of low-dose naloxone 
[14], [27]. In the present study, postoperative pruritus 
was observed in about half of the patients in the 
control group, and only one patient in the 
experimental group. Also, almost 40% of patients 
receiving morphine alone experienced postoperative 
nausea; while none of the patients in the naloxone 
plus morphine group experienced it. In a systematic 
review and meta-analysis aimed at investigating the 
effect of low-dose intravenous naloxone on the 
incidence of postoperative nausea and vomiting and 
the intensity of postoperative pain, it was found that 
low-dose naloxone had no significant effect on the 
incidence rates of postoperative nausea and vomiting 
and also the need for opioids after the surgery. 
However, more studies are recommended to 
generalise [28]. In another meta-analysis, He et al., 
[29] concluded that naloxone could effectively prevent 
and reduce the incidence of opioid-induced nausea, 
vomiting, and pruritus. These findings suggest the 
need for further studies to evaluate the effects of low-
dose naloxone on opioid-induced complications. 
The results of the present study showed that 
adding low dose naloxone to intrathecal morphine did 
not significantly change postoperative pain intensity in 
the patients undergone elective C-section using spinal 
anaesthesia; however, significantly decreased the 
severity of postoperative nausea and pruritus. 
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